Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection.
Acharya, P., Tolbert, W.D., Gohain, N., Wu, X., Yu, L., Liu, T., Huang, W., Huang, C.C., Kwon, Y.D., Louder, R.K., Luongo, T.S., McLellan, J.S., Pancera, M., Yang, Y., Zhang, B., Flinko, R., Foulke, J.S., Sajadi, M.M., Kamin-Lewis, R., Robinson, J.E., Martin, L., Kwong, P.D., Guan, Y., DeVico, A.L., Lewis, G.K., Pazgier, M.(2014) J Virol 88: 12895-12906
- PubMed: 25165110 
- DOI: 10.1128/JVI.02194-14
- Primary Citation of Related Structures:  
4H8W, 4R4B, 4R4F, 4R4H, 4R4N - PubMed Abstract: 
The RV144 vaccine trial implicated epitopes in the C1 region of gp120 (A32-like epitopes) as targets of potentially protective antibody-dependent cellular cytotoxicity (ADCC) responses. A32-like epitopes are highly immunogenic, as infected or vaccinated individuals frequently produce antibodies specific for these determinants ...